Raymond C Koehler Selected Research

20-hydroxyeicosa-6(Z),15(Z)-dienoic acid

3/2009

Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raymond C Koehler Research Topics

Disease

34	Ischemia 01/2021 - 03/2002
24	Infarction (Infarctions) 01/2022 - 06/2003
21	Brain Ischemia (Cerebral Ischemia) 12/2021 - 03/2002
20	Hypoxia (Hypoxemia) 01/2022 - 04/2002
15	Heart Arrest (Cardiac Arrest) 12/2021 - 08/2003
14	Stroke (Strokes) 01/2022 - 05/2003
14	Brain Injuries (Brain Injury) 01/2021 - 04/2005
14	Hypothermia 01/2021 - 08/2003
14	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2017 - 03/2002
9	Ischemic Stroke 12/2020 - 07/2007
7	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2021 - 05/2015
6	Asphyxia (Suffocation) 01/2020 - 08/2003
5	Cerebral Hemorrhage 01/2021 - 07/2015
5	Hypertension (High Blood Pressure) 11/2013 - 10/2002
4	Wounds and Injuries (Trauma) 12/2021 - 12/2006
4	Hypotension (Low Blood Pressure) 11/2013 - 10/2007
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 01/2019
3	Reperfusion Injury 12/2021 - 09/2017
3	Seizures (Absence Seizure) 01/2021 - 06/2005
3	Brain Edema (Cerebral Edema) 01/2021 - 12/2017
3	Neuroinflammatory Diseases 01/2021 - 01/2019
3	Neurologic Manifestations (Neurological Manifestations) 01/2021 - 01/2011
3	Hypercapnia 03/2012 - 10/2003
2	Inflammation (Inflammations) 12/2021 - 09/2018
2	Hemorrhage 01/2020 - 12/2017
2	Necrosis 01/2017 - 02/2008
2	Hyperammonemia 10/2010 - 06/2005
2	Hyperemia 08/2008 - 05/2004

Drug/Important Bio-Agent (IBA)

11	Oxygen (Dioxygen)IBA 01/2021 - 03/2002
10	salicylhydroxamic acid (SHAM)IBA 01/2022 - 08/2003
10	Hemoglobins (Hemoglobin)IBA 09/2017 - 03/2002
9	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 01/2021 - 08/2008
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2005
7	PolymersIBA 06/2017 - 10/2002
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2010 - 06/2003
6	Halothane (Fluothane)FDA Link 03/2008 - 06/2003
5	Arachidonic Acid (Vitamin F)IBA 01/2019 - 12/2006
5	1- (3,4- dichlorophenyl)acetyl- 2- (1- pyrrolidinyl)methylpiperidineIBA 03/2006 - 06/2003
4	CytokinesIBA 01/2022 - 01/2018
4	Epoxide HydrolasesIBA 12/2021 - 01/2017
4	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2019 - 05/2004
4	Neuroprotective AgentsIBA 08/2011 - 07/2003
4	AlbuminsIBA 01/2009 - 03/2002
4	kappa Opioid Receptors (kappa Opioid Receptor)IBA 03/2006 - 06/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021 - 07/2010
3	Epinephrine (Adrenaline)FDA LinkGeneric 12/2021 - 04/2014
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 07/2010
3	Superoxide DismutaseIBA 01/2020 - 09/2012
3	HET0016IBA 01/2019 - 03/2009
3	Apoptosis Inducing FactorIBA 06/2017 - 05/2010
3	AcidsIBA 06/2017 - 11/2015
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2011 - 02/2008
3	N-Methylaspartate (NMDA)IBA 06/2011 - 02/2008
3	Dopamine (Intropin)FDA LinkGeneric 07/2007 - 02/2003
2	Coloring Agents (Dyes)IBA 01/2022 - 01/2018
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2010
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 06/2011
2	Adenosine Diphosphate (ADP)IBA 01/2021 - 07/2009
2	Quinolinic AcidIBA 01/2021 - 10/2020
2	Collagenases (Collagenase)FDA Link 01/2021 - 07/2015
2	IronIBA 01/2021 - 01/2011
2	Carbon MonoxideIBA 01/2021 - 12/2012
2	AmidesIBA 12/2020 - 07/2015
2	polynitroxylated pegylated hemoglobinIBA 01/2020 - 09/2017
2	CatalaseIBA 01/2020 - 09/2012
2	CarboxyhemoglobinIBA 01/2020 - 04/2002
2	Carbon DioxideIBA 10/2018 - 01/2017
2	Oxyhemoglobins (Oxyhemoglobin)IBA 10/2018 - 01/2018
2	Isoflurane FDA LinkGeneric 01/2018 - 03/2008
2	Messenger RNA (mRNA)IBA 01/2018 - 12/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2017
2	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2017 - 12/2011
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 06/2017 - 07/2010
2	Poly Adenosine Diphosphate RiboseIBA 06/2017 - 06/2011
2	CaspasesIBA 01/2017 - 07/2010
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 11/2015 - 10/2013
2	Adenosine Triphosphate (ATP)IBA 11/2015 - 01/2006
2	PEG-hemoglobinIBA 12/2012 - 10/2010
2	AntioxidantsIBA 09/2012 - 01/2011
2	EUK-134IBA 09/2012 - 01/2011
2	Poly (ADP-Ribose) Polymerase-1IBA 06/2011 - 05/2010
2	Glutamine (L-Glutamine)FDA Link 10/2010 - 06/2005
2	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 10/2010 - 06/2005
2	Group IV Phospholipases A2IBA 07/2010 - 12/2006
2	EnzymesIBA 07/2010 - 05/2010
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2010 - 01/2005
2	SolutionsIBA 01/2009 - 05/2006
2	Estradiol (Delestrogen)FDA LinkGeneric 07/2007 - 04/2006

Therapy/Procedure

13	Resuscitation 12/2021 - 08/2003
11	Induced Hypothermia 01/2021 - 02/2008
9	Rewarming 01/2021 - 08/2003
5	Lasers (Laser) 11/2013 - 12/2003
4	Cardiopulmonary Resuscitation (CPR) 12/2021 - 04/2014
3	Anesthesia 01/2019 - 03/2008
3	Catheters 04/2012 - 04/2009
2	Therapeutics 01/2022 - 01/2017
2	Induced Heart Arrest (Cardioplegia) 01/2020 - 08/2011
2	Ligation 10/2018 - 01/2018
2	Tracheostomy 10/2014 - 04/2014